Nicole Seagriff

Dr. Nicole Seagriff graduated Boston College with a Bachelor of Science in Nursing in 2007 and then started as an RN in the Medical ICU at Yale New Haven Hospital, completing her Master of Science in Nursing degree at YSN in 2011 to become a Family Nurse Practitioner. While at Yale she recognized the need for access to primary care services for underserved patients and completed an additional year of training through the nation’s first nurse practitioner residency program at The Community Health Center, Inc (CHCI) in 2012. 

 

As a primary care provider at CHCI for the past decade, she concurrently serves as the On-Site Medical Director of the Norwalk and Stamford locations, managing clinical operations of three health centers and serving as the Clinical Program Director of the National Nurse Practitioner Residency Program. In 2016 she earned her Doctor of Nursing Practice degree from Duke University with a focus on genetic testing for breast cancer mutations in underserved populations. She then became the Clinical Program Director overseeing clinical aspects of the Nurse Practitioner Residency Training Program. 

 

Diagnosed with breast cancer twice before age 35, Dr. Seagriff is also President of The Pink Agenda, a 503(c) dedicated to raising money and awareness among young professionals for breast cancer research and care. Since its inception, The Pink Agenda has raised nearly $7 million and reached over 1,000 participants through its Speaker Series and other events. 

 

In 2011 she discovered she had a BRCA2 mutation, which allowed her to seek high-risk screening and discover early-stage breast cancer later that year. She was treated at Memorial Sloan Kettering by the same surgeon who treated her mother 10 years prior. In the summer of 2020, she was found to have a reoccurrence of an invasive breast carcinoma. During the COVID-19 pandemic she underwent surgery, chemotherapy, and radiation and is currently on hormone therapy. 

 

Dr. Seagriff lives in New York City and enjoys climbing literal mountains, including summiting Mount Kilimanjaro just before the 2020 lockdown.